 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter C - Drugs: General |
|
|
Part 201 - Labeling |
|
|
Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin |
| § 201.50 - Statement of identity. |
| § 201.51 - Declaration of net quantity of contents. |
| § 201.55 - Statement of dosage. |
| § 201.56 - Requirements on content and format of labeling for human prescription drug and biological products. |
| § 201.57 - Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1). |
| § 201.58 - Waiver of labeling requirements. |
| § 201.59 - Effective date of 201.56, 201.57, 201.100(d)(3), and 201.100(e). |